Building Tools to Create Molecular Complexity for Next Generation Drugs

构建为下一代药物创造分子复杂性的工具

• 批准号: IM240100126
• 负责人: A/Prof Christopher Hyland
• 金额: $ 71.22万
• 依托单位: University of Wollongong
• 依托单位国家: 澳大利亚
• 项目类别: Mid-Career Industry Fellowships
• 财政年份: 2024
• 资助国家: 澳大利亚
• 起止时间: 2024-07-01 至 2028-06-30
• 项目状态: 未结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/IM240100126
• 关键词: Building; Tools; Create; Molecular; Complexity

This Fellowship aims to solve manufacturing challenges in the pharmaceutical industry by enabling the development and production of hard-to-make complex molecules, which display better safety profiles and are often more potent pharmaceuticals. This Fellowship will close the academia-industry innovation gap to solve this problem through the deployment of advanced catalytic reaction technology. The benefits will be increased competitiveness of the Australian pharmaceutical industry, access to better medicines and industrial training of an Industry Fellow to ensure long-term academia-industry collaboration.

该奖学金旨在通过实现难以制造的复杂分子的开发和生产来解决制药行业的制造挑战，这些分子表现出更好的安全性，并且通常是更有效的药品。这项奖学金将缩小学术界的创新差距，以通过部署先进的催化反应技术来解决这一问题。澳大利亚制药行业的竞争力将提高竞争力，获得更好的药物和工业培训的竞争力，以确保长期的学术界合作。